News for Boral Limited (BOALF)

FAVO Capital (OTC: FAVO) will participate in the D. Boral Capital Inaugural Global Conference on May 14, 2025, in New York City. CEO Vincent Napolitano and

D. Boral Capital Acted as Joint Bookrunner to Decent Holding Inc. (Nasdaq: DXST) in connection with its $5.0 Million Initial Public Offering

374water Inc.'s Nagar Yaacov sells $33,337 in stock

Narsoplimab shows promise in reducing mortality for TA-TMA patients

D. Boral Capital Served as Placement Agent to Nature's Miracle Holding, Inc. Announces Up to $29.7 Million Financing

NMHI stock touches 52-week low at $1.77 amid market challenges

Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering

SCWO Stock Hits 52-Week Low at $0.71 Amid Market Challenges

**media[493711]**

FORT LAUDERDALE, FL / ACCESSWIRE / December 12, 2024 / FAVO Capital, Inc. (OTC PINK:FAVO), a leading provider of alternative financing solutions in the Private

FDA grants Orphan Drug status to CervoMed's dementia drug

PAPL stock touches 52-week low at $0.6 amid market challenges

The Calcium Sulfate Market is projected to grow from USD 277.8 million in 2024 to USD 415.2 million by 2034, with a CAGR of 4.1%. Key drivers include...

By Adam Solomon, Go-to-Market Strategy and Planning for Xfinity Growth.  Carbon Markets Overview

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Pollution Absorbing...

“Sustainable Construction Materials Market” from 2024-2034 with covered segments By Construction Type (Structural, and Non-structural), By Material Type...

Earnings call: ASX reports mixed results amid strategic investments